4.83
Xeris Biopharma Holdings Inc Aktie (XERS) Neueste Nachrichten
Northern Trust Corp Purchases 38,155 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings Inc (XERS) With A Potential Upside Of More Than 18.7% - Stocksregister
Jane Street Group LLC Decreases Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Announces Details for Analyst & Investor Day | XERS Stock News - GuruFocus
Xeris Announces Details for Analyst & Investor Day - Business Wire
Balyasny Asset Management L.P. Makes New Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
The Manufacturers Life Insurance Company Lowers Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Leerink Partnrs Estimates Xeris Biopharma Q2 Earnings - Defense World
Voya Investment Management LLC Reduces Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Raymond James Financial Inc. Purchases New Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Hsbc Holdings PLC Decreases Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Position Raised by Price T Rowe Associates Inc. MD - Defense World
Xeris Biopharma Holdings, Inc. (XERS): Among the Unstoppable Growth Stocks to Invest in Now - Yahoo Finance
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives $6.10 Consensus Target Price from Analysts - Defense World
Xeris Biopharma (NASDAQ:XERS) Stock Price Expected to Rise, Oppenheimer Analyst Says - Defense World
Xeris Biopharma Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2025 Earnings Call Transcript - Insider Monkey
Oppenheimer Increases Price Target for Xeris Biopharma (XERS) to $7 | XERS Stock News - GuruFocus
XERS: Oppenheimer Raises Price Target for Xeris Biopharma Holdings | XERS Stock News - GuruFocus
Xeris Biopharma: Q1 Earnings Snapshot - New Haven Register
Xeris Biopharma Reports Record First Quarter 2025 Financial Results - BioSpace
Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highli - GuruFocus
Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements - GuruFocus
Xeris Biopharma Reports Strong Q1 2025 Growth - TipRanks
Xeris Pharmaceuticals Reports Strong Earnings and Growth - TipRanks
Xeris Biopharma raises revenue guidance for 2025 to $260M-$275M amid strong Recorlev growth - MSN
Xeris Biopharma Holdings, Inc. SEC 10-Q Report - TradingView
Transcript : Xeris Biopharma Holdings, Inc., Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Market Recap: Xeris Biopharma Holdings Inc (XERS)’s Positive Momentum, Closing at 4.48 - DWinneX
Xeris Biopharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Xeris Biopharma (XERS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
XERS Revenue Surpasses Expectations with Strong Q1 Performance | XERS Stock News - GuruFocus
MetLife Investment Management LLC Has $296,000 Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - The AM Reporter
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Bought by Wells Fargo & Company MN - Defense World
Xeris Pharmaceuticals Q1 2025 Earnings Preview - MSN
Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings (NASDAQ:XERS) - Seeking Alpha
Barclays PLC Purchases 23,170 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings Inc [XERS] Records 50-Day SMA of $4.51 - knoxdaily.com
Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025 - BioSpace
LPL Financial LLC Decreases Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma (XERS) Projected to Post Earnings on Thursday - Defense World
Prepare Yourself for Liftoff: Xeris Biopharma Holdings Inc (XERS) - Sete News
Market Momentum Report: Xeris Biopharma Holdings Inc (XERS)’s Positive Close at 4.41 - DWinneX
Xeris Biopharma Holdings Inc (XERS) stock analysis: A simple moving average approach - uspostnews.com
Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long - simplywall.st
Recent Insider Activity Suggests Potential Gains for Xeris Biopharma Holdings Inc (XERS) - knoxdaily.com
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Bought by Russell Investments Group Ltd. - Defense World
Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit - Yahoo
Xeris Biopharma Holdings Inc’s Banking’s 100-Day Moving Average at 3.96: Will the Stock Break Through? - investchronicle.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):